Gerard Morton

7.8k total citations · 2 hit papers
242 papers, 5.6k citations indexed

About

Gerard Morton is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gerard Morton has authored 242 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Pulmonary and Respiratory Medicine, 133 papers in Radiation and 41 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gerard Morton's work include Prostate Cancer Diagnosis and Treatment (194 papers), Prostate Cancer Treatment and Research (170 papers) and Advanced Radiotherapy Techniques (133 papers). Gerard Morton is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (194 papers), Prostate Cancer Treatment and Research (170 papers) and Advanced Radiotherapy Techniques (133 papers). Gerard Morton collaborates with scholars based in Canada, United States and Australia. Gerard Morton's co-authors include Cyril Danjoux, Richard Choo, Andrew Loblaw, Patrick Cheung, Hans T. Chung, William Morris, Scott Tyldesley, Howard Pai, Jeremy Hamm and Ross Halperin and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Gerard Morton

234 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer

2016 505 citations Gerard Morton et al. International Journal of Radiation Oncology*Biology*Physics profile →
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer

2018 225 citations Jeff M. Michalski, Jennifer Moughan et al. profile →

Peers

Countries citing papers authored by Gerard Morton

Since Specialization

Citations

This map shows the geographic impact of Gerard Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Morton more than expected).

Fields of papers citing papers by Gerard Morton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Morton. The network helps show where Gerard Morton may publish in the future.

Co-authorship network of co-authors of Gerard Morton

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard Morton. A scholar is included among the top collaborators of Gerard Morton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard Morton. Gerard Morton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087) 2025 ·Radiotherapy and Oncology ·Gerard Morton, (unknown), Maroie Barkati, Joelle Helou, Tamim Niazi, John W. Robinson, D.A. Loblaw, (unknown), Hyun‐Tai Chung, Guila Delouya, Cynthia Ménard, Ángel G. Martín, Peter Chung, Deidre Batchelar, Michael Brundage, Kimberly Whelan, Keyue Ding, Wendy R. Parulekar	0
2	Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy: A 9-year update 2024 ·Radiotherapy and Oncology ·(unknown), (unknown), (unknown), Hans T. Chung, Chia‐Lin Tseng, (unknown), (unknown), Ewa Szumacher, (unknown), Liying Zhang, (unknown), (unknown), Gerard Morton	9
3	Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Jeff M. Michalski, Jennifer Moughan, James A. Purdy, Deborah Watkins Bruner, Mahul B. Amin, Jean-Paul Bahary, Harold Lau, (unknown), Don Yee, Gerard Morton, Robert T. Dess, Desiree E. Doncals, Michael Lock, Himanshu Lukka, (unknown), Éric Vigneault, Young Kwok, J. M. Robertson, David A. Schwartz, Howard M. Sandler	3
4	44 Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer 2023 ·Radiotherapy and Oncology ·Jiheon Song, Mark T. Corkum, Andrew Loblaw, Hans T. Chung, Chia‐Lin Tseng, (unknown), Ewa Szumacher, Stanley K. Liu, William Chu, Melanie Davidson, Matt Wronski, Liying Zhang, Alexandre Mamedov, Gerard Morton	0
5	Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Jiheon Song, Mark T. Corkum, D.A. Loblaw, Hans T. Chung, (unknown), Patrick Cheung, Ewa Szumacher, Stanley K. Liu, William Chu, Melanie Davidson, (unknown), Liping Zhang, Alexandre Mamedov, Gerard Morton	1
6	Radiation therapy after radical surgery in prostate cancer 2023 ·ecancermedicalscience ·(unknown), Gerard Morton, (unknown), (unknown), (unknown), (unknown)	4
7	A personalized decision aid for prostate cancer shared decision making 2021 ·BMC Medical Informatics and Decision Making ·H.P. Bagshaw, (unknown), Nastaran Heidari, David Scheinker, Alan Pollack, Radka Stoyanova, Eric M. Horwitz, Gerard Morton, Amar U. Kishan, Mark K. Buyyounouski	8
8	Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial 2021 ·Radiotherapy and Oncology ·Rachel Glicksman, Andrew Loblaw, Gerard Morton, Ewa Szumacher, Hans T. Chung, Danny Vesprini, William Chu, Stanley K. Liu, Richard Choo, Andrea Deabreu, Alexandre Mamedov, Liying Zhang, Patrick Cheung	12
9	Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: An exploratory study 2020 ·Radiotherapy and Oncology ·Hanzhi Wang, Lucas C. Mendez, Gerard Morton, Andrew Loblaw, Aruz Mesci, Hans T. Chung, Stephanie Chan, Xiaodong Huang, Michelle R. Downes, Danny Vesprini, Stanley K. Liu	7
10	Potential applications of the quantitative susceptibility mapping (QSM) in MR-guided radiation therapy 2019 ·Physics in Medicine and Biology ·(unknown), Moti Paudel, Ananth Ravi, Ana Pejović‐Milić, Gerard Morton, Greg J. Stanisz	9
11	Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients 2019 ·Brachytherapy ·(unknown), William Y. Song, (unknown), Ana Pejović‐Milić, Gerard Morton, Greg J. Stanisz	6
12	Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786) 2018 ·Clinical Oncology ·Éric Vigneault, Gerard Morton, Wendy R. Parulekar, Tamim Niazi, (unknown), Maroie Barkati, Peter Chung, Wayne Koll, (unknown), (unknown), Keyue Ding, Andrew Loblaw	5
13	Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy 2017 ·Brachytherapy ·(unknown), Jure Murgić, Ivan Kruljac, (unknown), Laura D’Alimonte, Lin Lu, (unknown), (unknown), Gerard Morton, Andrew Loblaw, Hans T. Chung, Ananth Ravi	4
14	Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy. 2012 ·PubMed ·Perakaa Sethukavalan, Patrick Cheung, Colin Tang, Harvey Quon, Gerard Morton, Robert K. Nam, Andrew Loblaw	38
15	Radiation treatment of bladder squamous cell carcinoma in a patient with spina bifida: A case report 2012 ·Canadian Urological Association Journal ·(unknown), Gerard Morton, Hans T. Chung	4
16	Health-Related Quality of Life After Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Prostate Cancer 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Gerard Morton, D.A. Loblaw, Hans T. Chung, (unknown), Raxa Sankreacha, Andrea Deabreu, Liying Zhang, Alexandre Mamedov, Patrick Cheung, Deidre Batchelar, Cyril Danjoux, Ewa Szumacher	57
17	Delivery of Brachytherapy for Cervical Cancer: Organisational and Technical Advice to Facilitate High-quality Care 2010 ·Clinical Oncology ·Gerard Morton, Cindy Walker‐Dilks, Fulvia Baldassarre, David D’Souza, Conrad Falkson, (unknown), Eric Gutierrez, Kate Bak	6
18	Prospective Assessment of Gastrointestinal and Genitourinary Toxicity of Salvage Radiotherapy for Patients With Prostate-Specific Antigen Relapse or Local Recurrence After Radical Prostatectomy 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Maria Pearse, Richard Choo, Cyril Danjoux, Sandra Gardner, Gerard Morton, Ewa Szumacher, Andrew Loblaw, Patrick Cheung	28
19	Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Richard Choo, Gillian Thomas, Tony Woo, David Lee, (unknown), N. Iscoe, Cyril Danjoux, (unknown), Gerard Morton, Sarat Chander	53
20	Target position variability throughout prostate radiotherapy 1998 ·International Journal of Radiation OncologyBiologyPhysics ·Laura A. Dawson, Katherine Mah, Edmée Franssen, Gerard Morton	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact